Lack of effective systemic therapy for recurrent clear cell carcinoma of the ovary
- 1 May 2007
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (2) , 404-408
- https://doi.org/10.1016/j.ygyno.2006.12.024
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Paclitaxel-platinum combination chemotherapy for advanced or recurrent ovarian clear cell adenocarcinoma: a multicenter trialInternational Journal of Gynecologic Cancer, 2006
- Clear-cell cancer of the ovary?is it chemosensitive?International Journal of Gynecologic Cancer, 2005
- Complete response to irinotecan hydrochloride and nedaplatin in a patient with advanced ovarian clear cell carcinomaInternational Journal of Clinical Oncology, 2004
- Clear Cell Carcinoma of the OvaryAmerican Journal of Clinical Oncology, 2001
- Clinical Characteristics of Clear Cell Carcinoma of the OvaryGynecologic Oncology, 1998
- Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III DiseaseGynecologic Oncology, 1996
- Clear cell carcinoma of the ovary: A study of 59 casesGynecologic Oncology, 1989
- Ovarian Clear Cell CarcinomaInternational Journal of Gynecological Pathology, 1989
- Endometrioid and Clear Cell Carcinoma of the OvaryInternational Journal of Gynecological Pathology, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958